Medical EmExome: Clinical Exome Sequencing
Improved turnaround times and reduced pricing
3 years of clinical experience have optimized the process, making clinical exome sequencing more cost-effective and less time-consuming.
Enhanced coverage of disease-associated genes
Enhanced coverage of ~4600 medically relevant and known disease-associated genes. With EmExome Boost, choose a panel relevant to the patient's phenotype to ensure complete coverage of all exons on the gene panel.
Flexible testing options
5 testing options: Medical EmExome (Family Trios); Medical EmExome (Proband Only); Medical EmExome Array: Deletion/Duplication Analysis; Sanger Confirmation and Interpretation; and Interpretation Only.